Cancer Biomarkers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2641 | Report Format : | Status : Upcoming |

Abstract

Global Cancer Biomarkers Market: Overview

Cancer biomarkers are molecules which are released in the presence of a tumor or show a particular indication in the body related to the presence of cancer. These are molecular substances or a physical condition that shows the presence of cancer cells in the body. These kinds of molecules are usually found in urine, tissues, blood, serum, and other body fluids that point out any kind of abnormal method or a syndrome. Cancer biomarkers are noticeable substances that can be utilized as a sign of biological state for tumor, therefore it can be utilized to prognostic stages of cancer and analyze test as well.

Global Cancer Biomarkers Market: Growth Factors

The most significant factors which are driving the development of the cancer biomarkers market are growing occurrence of cancer, progress in omics technologies, rising healthcare outflow, development in R&D funding from private bodies and government, and growing demand & popularity for personalized drugs in cancer therapies. The demand and popularity of diagnostic markets are growing at a rapid rate where usual diagnostic equipment is unrelenting on producing accurate and reliable results. The demand for the global cancer biomarker market is increasing owing to the enhancement in technologies, tests, clinical laboratory, thus propelling the market growth to a great extent.

Global Cancer Biomarkers Market: Segmentation

The global cancer biomarkers market is divided into type, cancer type, and profiling technology. By type, the cancer biomarkers market is classified into three divisions, namely, genetic biomarkers protein biomarkers, and other biomarkers (includes cell, viral, and carbohydrate biomarkers). It is projected that the protein biomarkers division is having the highest share in the global cancer biomarkers market. By cancer type, the cancer biomarkers market is split into prostate cancer, lung cancer, cervical cancer, breast cancer, colorectal cancer, and other cancers (which includes leukemia, pancreatic cancers, melanoma, kidney, gastric, and liver). It is predicted that the breast cancer division will hold the highest market share. It is predicted that it is mainly due to the increased occurrences of breast cancer in the past few years, improved knowledge about breast cancer diagnosis, and rising study focuses on breast cancer. Based on profiling technology, the market is classified into imaging technologies, omics technologies, cytogenetics, immunoassays, and bioinformatics. The omics technologies division is projected to have the largest market share in the global cancer biomarkers market. The largest share of this division is anticipated due to the augmented adoption of advanced technologies in biomarker discovery and growth of omics-based tests for drug progress and cancer diagnosis method.

Global Cancer Biomarkers Market: Regional Analysis

North America and Europe are anticipated to dominate the global cancer biomarkers market. The factors that are contributing to the cancer biomarkers market are the high cancer detection and diagnostic methods, huge investment in research and development by biotechnology and pharmaceutical companies, and improved healthcare infrastructure which supports the R&D activities by utilizing biomarkers. Markets in rising economies such as the Latin America and the Asia Pacific are projected to develop at a significant rate due to growing funding for growing prevalence of cancer, cancer biomarker research, increasing demand for targeted and personalized drug therapies, and growing number of clinical trials. In addition, cancer biomarkers market in the Middle East and Africa is expected to grow at a considerable rate in the coming years

Global Cancer Biomarkers Market: Competitive Players

Some of the most important market players in the global cancer biomarkers market are Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Illumina, Inc., Hologic Inc., Merck & Co. Inc., Roche Diagnostics Ltd., and Qiagen NV, among others.

Global Cancer Biomarkers Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Single-Cell Genome Sequencing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2962 | Report Format:

Global Single-Cell Genome Sequencing Market: Overview Single-cell genome sequencing is a technique that is used to study the sequence data with upsurge next-generation sequencing expertise from a cell. This method has come up as a potent instrument that aims to offer intelligence and understandi...Read More

Biobanks Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2958 | Report Format:

Global Biobanks Market: Overview Biobanks can be referred as a storage place that stores, distributes, and collects the biological materials of the human beings that comprise of plasma, purified DNA, blood, saliva, and other biospecimens. Biobanks help in keeping the records of the persons perso...Read More

Microplate Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2839 | Report Format:

Global Microplate Systems Market: Overview Microbial interactions are generally found in all biological interactions and processes, which also contain mixed infections from animals, plants, as well as humans. At present, microplate system is considered to be one of the most significant devices a...Read More

Polymerase Chain Reaction (PCR) Market by Product (Instruments, Reagents and Consumables and Software) and End User: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Mar-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-2720 | Report Format:

The report covers forecast and analysis for the polymerase chain reaction market on a global and regional level. The study provides historic data of 2015 to 2017 along with a forecast from 2018 to 2023 based on revenue (USD Billion). The study includes drivers and restraints for the polymerase cha...Read More

Cellular Health Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2655 | Report Format:

Global Cellular Health Screening Market: Overview Cellular health screening helps the physicians to know how the body is running and functioning at a cellular level, which includes clearer knowledge of how different bodily systems are functioning and how aging process have affected them. The cle...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.